# FDA Inspection 945856 - Thrombolysis in Myocardial Infarction (TIMI) Study Group - August 25, 2015

Source: https://www.keypedia.com/records/fda_inspections/thrombolysis-in-myocardial-infarction-timi-study-group/4cdefdc0-b839-4568-bf73-f62dcb861936
Source feed: FDA_Inspections

> FDA Inspection 945856 for Thrombolysis in Myocardial Infarction (TIMI) Study Group on August 25, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 945856
- Company Name: Thrombolysis in Myocardial Infarction (TIMI) Study Group
- Inspection Date: 2015-08-25
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1029812 - 2017-10-12](https://www.keypedia.com/records/fda_inspections/thrombolysis-in-myocardial-infarction-timi-study-group/8b28f4f4-962d-4eb0-a1d2-559d2dd86144)

Company: https://www.keypedia.com/companies/thrombolysis-in-myocardial-infarction-timi-study-group/ccef5643-4dd8-495d-b5ca-736dd6e91f62

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c